Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Kulp

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Structure (London, England : 1993)|February 24, 2015
The membrane- and soluble-protein helix-helix interactome: similar geometry via different interactionsShao-Qing Zhang, Daniel W Kulp, Chaim A Schramm, et al.
Frontiers in Medical Technology|January 20, 2022
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious DiseasesZiyang Xu, Ami Patel, Nicholas J Tursi, et al.
Virology|April 15, 2014
Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion proteinJohn T Bates, Christopher J Keefer, James C Slaughter, et al.
Journal of Computational Chemistry|May 9, 2012
Structural informatics, modeling, and design with an open-source Molecular Software Library (MSL)Daniel W Kulp, Sabareesh Subramaniam, Jason E Donald, et al.
Journal of Structural and Functional Genomics|February 11, 2005
A structure-based method for identifying DNA-binding proteins and their sites of DNA-interactionWilliam A McLaughlin, Daniel W Kulp, Joanna de la Cruz, et al.
Human Vaccines & Immunotherapeutics|November 27, 2023
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal modelsViviane M Andrade, Igor Maricic, Richa Kalia, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Consensus motif for integrin transmembrane helix associationBryan W Berger, Daniel W Kulp, Lisa M Span, et al.
Virology|March 11, 2017
Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody inductionEma T Crooks, Keiko Osawa, Tommy Tong, et al.
JCI Insight|December 12, 2022
A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapyDevivasha Bordoloi, Pratik S Bhojnagarwala, Alfredo Perales-Puchalt, et al.
Immunity|December 31, 2017
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine ImmunogensRobert K Abbott, Jeong Hyun Lee, Sergey Menis, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Structure (London, England : 1993)|February 24, 2015
The membrane- and soluble-protein helix-helix interactome: similar geometry via different interactionsShao-Qing Zhang, Daniel W Kulp, Chaim A Schramm, et al.
Frontiers in Medical Technology|January 20, 2022
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious DiseasesZiyang Xu, Ami Patel, Nicholas J Tursi, et al.
Virology|April 15, 2014
Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion proteinJohn T Bates, Christopher J Keefer, James C Slaughter, et al.
Journal of Computational Chemistry|May 9, 2012
Structural informatics, modeling, and design with an open-source Molecular Software Library (MSL)Daniel W Kulp, Sabareesh Subramaniam, Jason E Donald, et al.
Journal of Structural and Functional Genomics|February 11, 2005
A structure-based method for identifying DNA-binding proteins and their sites of DNA-interactionWilliam A McLaughlin, Daniel W Kulp, Joanna de la Cruz, et al.
Human Vaccines & Immunotherapeutics|November 27, 2023
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal modelsViviane M Andrade, Igor Maricic, Richa Kalia, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Consensus motif for integrin transmembrane helix associationBryan W Berger, Daniel W Kulp, Lisa M Span, et al.
Virology|March 11, 2017
Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody inductionEma T Crooks, Keiko Osawa, Tommy Tong, et al.
JCI Insight|December 12, 2022
A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapyDevivasha Bordoloi, Pratik S Bhojnagarwala, Alfredo Perales-Puchalt, et al.
Immunity|December 31, 2017
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine ImmunogensRobert K Abbott, Jeong Hyun Lee, Sergey Menis, et al.
Pageof 8